WE CARE FOR CONTINUOUS GROWTH

Curetis Facts & Figures

Business segment:

  • molecular microbiology solutions for hospitals

Founded:

  • in August 2007

Listed: 

  • Euronext Amsterdam and Euronext Brussels
  • ticker symbol "CURE"
  • issued shares: 20,908,802

Locations:

  • Germany: Holzgerlingen (headquarters) and Bodelshausen (cartridge production)
  • France: Strasbourg
  • Austria: Vienna (Ares Genetics)
  • The Netherlands (for the Benelux area): Amsterdam
  • Unted Kingdom: London
  • United States: San Diego, CA

Number of employees:

  • 120+ (as of June 30, 2018)

Commercialized Products

  • Unyvero Platform for fully automated sample-to-answer molecular diagnostics
  • Unyvero Application Cartridges for syndromic testing for pneumonia, implant and tissue infection, blood stream-related infections, intra-abdominal infections and urinary tract infections

ISO certificate:

Our Milestones